Markets

The company’s third UK facility adds 95,000+ cubic feet of GxP-compliant, environmentally controlled storage capacity and serves as a consolidation point for regulated materials across the UK, EMEA, and beyond.

Transaction highlights Advances Alfasigma’s M&A-led global growth strategy, purposely focused on immunology and gastroenterology. Synergy with Alfasigma’s specialty rheumatology portfolio, adding Nordic Pharma’s rheumatoid arthritis business, including the Nordimet® franchise.…

Record Quarterly Revenue and Adjusted EBITDA(1) Driven by Acquisition of Sanity Group

Recognition highlights the MultiBank Group Founder and Chairman’s leadership, global experience and contribution to the financial services industry

Silence Therapeutics plc (“Silence” or the “Company”), a global clinical-stage biotechnology company developing novel short interfering RNA (“siRNA”) therapies, today announced that it has commenced an underwritten public offering of…

New Funding Further Solidifies Point2’s e‑Tube Technology Platform as the Foundation for Next-Generation AI Data-Center Interconnect

Enterprise AI SaaS leader to accelerate Brightfin's AI-Native platform for IT financial management

Harbor Deploy is the first AI deployment offering built exclusively for law firms and corporate legal departments, bringing the embedded-engineering model now reshaping enterprise AI to the industry where confidentiality,…

AT&T customers at Mississippi State University’s Davis Wade Stadium in Starkville are getting a boost in wireless connectivity following the deployment of a new AT&T-led distributed antenna system, or DAS,…

Trial met its primary endpoint, with a significantly higher proportion of clinical responders on divesiran (88%) compared to placebo (19%); placebo-adjusted response rate = 69% Both divesiran dose groups showed…